UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
DFP Healthcare Acquisitions Corp.
(Exact name of registrant as specified in its charter)
Delaware |
|
84-3562323 |
|
|
|
780 Third Avenue, 37th Floor |
|
10017 |
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Name of each exchange on which |
Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant |
|
The Nasdaq Stock Market LLC |
|
|
|
Class A common stock, par value $0.0001 per share |
|
The Nasdaq Stock Market LLC |
|
|
|
Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share |
|
The Nasdaq Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. x
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. o
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. o
Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333- 236578
Securities to be registered pursuant to Section 12(g) of the Act: N/A
Item 1. Description of Registrants Securities to be Registered.
The securities to be registered hereby are the units, Class A common stock, par value $0.0001 per share, and warrants to purchase Class A common stock of DFP Healthcare Acquisitions Corp. (the Registrant). The description of the units, Class A common stock and warrants set forth under the heading Description of Securities in the Registrants prospectus forming a part of its Registration Statement on Form S-1 (File No. 333- 236578), originally filed with the U.S. Securities and Exchange Commission on February 21, 2020, as thereafter amended and supplemented from time to time (the Registration Statement), to which this Form 8-A relates is incorporated by reference herein. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and that are subsequently filed are hereby also incorporated by reference herein.
Item 2. Exhibits.
The following exhibits have been filed as exhibits to the Registration Statement and are incorporated herein by reference:
3.1 |
|
|
|
|
|
3.2 |
|
|
|
|
|
4.1 |
|
|
|
|
|
4.2 |
|
|
|
|
|
4.3 |
|
|
|
|
|
4.4 |
|
|
|
|
|
10.1 |
|
|
|
|
|
10.2 |
|
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
|
DFP HEALTHCARE ACQUISITIONS CORP. | ||
|
| ||
Date: March 10, 2020 |
By: |
/s/ Christopher Wolfe | |
|
|
Name: |
Christopher Wolfe |
|
|
Title: |
Chief Financial Officer |